In parallel the wild type (WT) and FXR knockout mice developed NASH when fed the WTD (the FXR KO mice had more inflammatory phenotypes than WT mice), which was halted with antibiotic treatment suggesting a link between inflammation in the liver, bile acids, and gut microbiome. Here, NR1H4 is linked to metabolic dysfunction-associated steatohepatitis.